IDiyas

For the Inventor, By the Inventor

Camarillo, CA, United States of America

Randall W Hungate

USPTO Granted Patents = 17 


 

Average Co-Inventor Count = 16.0

ph-index = 5

Forward Citations = 101(Granted Patents)


Location History:

  • San Francisco, CA (US) (2010 - 2011)
  • Camarillo, CA (US) (2007 - 2015)
  • Longmont, CA (US) (2017)

Company Filing History:

goldMedal17 out of 1,970 
 
Amgen Inc.
 patents
silverMedal3 out of 55 
 
Biovitrum Ab
 patents
where one patent can have more than one assignee

Years Active: 2007-2017

where 'Filed Patents' based on already Granted Patents

17 patents (USPTO):
1. 9556135 - Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use (2017-01-31),
2. 9066954 - Fused heterocyclic derivatives and methods of use (2015-06-30),
3. 8686011 - Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 (2014-04-01),
4. 8541592 - Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (2013-09-24),
5. 8163766 - Beta-secretase modulators and methods of use (2012-04-24),
6. 8030346 - Heterocyclic quinolone derivatives that inhibit prolyl hydroxylase activity (2011-10-04),
7. 8017626 - Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereof (2011-09-13),
8. 8012968 - Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof (2011-09-06),
9. 7973047 - Beta-Secretase modulators and methods of use (2011-07-05),
10. 7872009 - Beta-Secretase modulators and methods of use (2011-01-18),
11. 7838676 - Beta-secretase modulators and methods of use (2010-11-23),
12. 7807700 - Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 (2010-10-05),
13. 7759337 - Phthalazine compounds and methods of use (2010-07-20),
14. 7745484 - Beta-secretase modulators and methods of use (2010-06-29),
15. 7728130 - Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity (2010-06-01),

Title: The Innovative Mind of Randall W. Hungate

Introduction

Randall W. Hungate, based in Camarillo, California, is a prolific inventor with an impressive portfolio of 17 patents. His work primarily focuses on biopharmaceuticals and compounds that target critical enzymatic activities linked to neurodegenerative diseases and cancer. With a commitment to innovation, Randall has significantly contributed to the scientific community through his research and inventions.

Latest Patents

Among Randall's latest patents is the development of amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists. This invention provides a new class of compounds that are instrumental in modulating beta-secretase enzyme (BACE) activity. The compounds are designed to combat disorders related to A-beta plaque formation, such as Alzheimer's Disease, cognitive impairments, and schizophrenia. Additionally, his patent on fused heterocyclic derivatives outlines selected compounds effective for the prophylaxis and treatment of diseases involving Hepatocyte Growth Factor (HGF) mediated diseases and cancer. These patents underscore his innovative approach to solving critical health challenges.

Career Highlights

Randall has spent significant parts of his career at leading companies such as Amgen Inc. and Biovitrum Ab. His roles in these organizations have anchored his reputation as a key player in pharmaceutical innovation, where he applied his expertise in medicinal chemistry and compound synthesis to advance new therapeutic options.

Collaborations

Throughout his career, Randall has collaborated with notable individuals such as Michael D. Bartberger and Christopher Michael Tegley. These partnerships have fostered a dynamic exchange of ideas and knowledge, enhancing the quality and application potential of his inventions.

Conclusion

Randall W. Hungate stands out as a prominent inventor dedicated to advancing healthcare through his innovative compounds and methods. His contributions continue to reflect a deep commitment to addressing complex medical conditions, with the potential to improve the lives of many individuals facing significant health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…